医学
前列腺切除术
淋巴结
四分位间距
腹腔镜前列腺根治术
解剖(医学)
前列腺癌
淋巴
生化复发
泌尿科
淋巴结切除术
前列腺特异性抗原
单变量分析
外科
癌症
多元分析
内科学
病理
作者
Ritsuki Yamaguchi,Shiori Murata,Hidetoshi Kokubun,Noriyuki Makita,Yohei Abe,Masashi Kubota,Naofumi Tsutsumi,Yoshio Sugino,Noriaki Utsunomiya,Takuya Okada,Koji Inoue,Mutushi Kawakita
出处
期刊:Hinyokika kiyo. Acta urologica Japonica
日期:2021-03-01
卷期号:67 (3): 83-90
标识
DOI:10.14989/actauroljap_67_3_83
摘要
From April 2007 to April 2018, we performed lymph node dissection in 305 cases of laparoscopic radical prostatectomy and 202 cases of robot-assisted radical prostatectomy at our hospital, and there were 68 cases with positive lymph node metastasis (pN1). Of these 68 cases, we examined retrospectively 62 cases in which extended lymph node dissection (ELND) was performed. The median number of removed lymph nodes was 25 (interquartile range [IQR] ; 18-34) and the median number of metastatic lymph nodes was 1 (IQR ; 1-3). Postoperative prostate-specific antigen (PSA) recurrence was observed in 40 of the 62 patients. The median time to PSA recurrence was 24 months. After univariate analysis, PSA at initial diagnosis (iPSA) of 10 ng/ml or more, pathological Gleason score (pGS) of 8 or more, total number of lymph node metastases of 2 or more, and positive surgical margin (RM+) were found to be riskfactors of PSA recurrence. In multivariate analysis, iPSA of 10 ng/ml or more, pGS of 8 or more and RM+ were independent riskfactors of PSA recurrence (p<0.05). In the cases without riskfactors such as iPSA≥10, pGS≥8, and RM+, immediate postoperative adjuvant therapy may be avoided even with pN1.
科研通智能强力驱动
Strongly Powered by AbleSci AI